Now showing items 1-6 of 6

    • Campero Soffia, Mario; Campero, Sebastián; Guerrero Peralta, Julia; Aouba, Aouba; Castro, Alex (Karger, 2016)
      A young male presented with panhypopituitarism (including diabetes insipidus) and temporal lobe epilepsy. A histology specimen of cutaneous papules was diagnostic of non- Langerhans histiocytosis. The diagnosis of ...
    • De Gregorio, Cristián; Contador, David; Díaz, Diego; Cárcamo, Constanza; Santapau, Daniela; Lobos González, Lorena; Acosta, Cristián; Campero Soffia, Mario; Carpio, Daniel; Gabriele, Caterina; Gaspari, Marco; Aliaga Tobar, Víctor; Maracaja Coutinho, Vinicius; Ezquer, Marcelo; Ezquer, Fernando (BMC, 2020)
      Background Diabetic polyneuropathy (DPN) is the most common and early developing complication of diabetes mellitus, and the key contributor for foot ulcers development, with no specific therapies available. Different studies ...
    • Campero Soffia, Mario; Ezquer, M.; Ezquer, Fernando (Johann Ambrosius Barth Verlag Medizinverlage Heidelberg GMBH, 2015)
      Objective: The mechanisms associated with nerve dysfunction and axonal loss in diabetes has not been fully clarified. Excitability and pathological aspects in nerves from diabetic mice were studied in order to explore the ...
    • Verdugo L., Renato; Campero Soffia, Mario; Castillo Carrasco, José; Cea Muñoz, Gabriel (Saunders, 2007)
    • Bostock, Hugh; Campero Soffia, Mario; Serra, J.; Ochoa, J. L. (OXFORD UNIV PRESS, 2005-09)
      Five patients with small-fibre neuropathy characterized by temperature-dependent spontaneous pain, hyperalgesia/allodynia and signs of neurogenic inflammation were studied clinically and thermographically, and by ...
    • Woudt, Lisanne; Di Capua, Gabriella A.; Krahn, Martin; Castiglioni, Claudia; Hughes García, Ricardo; Campero Soffia, Mario; Trangulao, Alejandra; González Hormazabal, Patricio; Godoy Herrera, Raúl; Levy, Nicolas; Urtizberea, Jon Andoni; Jara, Lilian; Bevilacqua, Jorge (WILEY-BLACKWELL, 2016)
      Introduction: Understanding the natural history of dysferlinopathy is essential to design and quantify novel therapeutic protocols. Our aim in this study was to assess, clinically and functionally, a cohort of patients ...